implementation

Digital

In a market saturated with articles highlighting the potential of generative AI, it’s crucial to also understand its limitations.

Digital

For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach.

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.